×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EPRX – eupraxia pharmaceuticals inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EPRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
07:17 am
eprx
Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months [Yahoo! Finance]
High
Report
Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months [Yahoo! Finance]
11/20
07:09 am
eprx
Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months [Globe and Mail, The (Toronto, Canada)]
High
Report
Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months [Globe and Mail, The (Toronto, Canada)]
11/20
07:00 am
eprx
Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months
High
Report
Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months
11/15
06:00 am
eprx
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
Medium
Report
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
11/14
05:27 pm
eprx
Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting [Yahoo! Finance]
Medium
Report
Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting [Yahoo! Finance]
11/14
05:00 pm
eprx
Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting
Medium
Report
Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting
11/14
07:35 am
eprx
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $9.00 price target on the stock.
Low
Report
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $9.00 price target on the stock.
11/13
05:08 pm
eprx
Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024 [Globe and Mail, The (Toronto, Canada)]
Low
Report
Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024 [Globe and Mail, The (Toronto, Canada)]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/20
08:58 am
eprx
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 20
Medium
Report
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 20
11/14
05:01 pm
eprx
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 14
Medium
Report
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 14
11/14
04:18 pm
eprx
Form SC 13G EUPRAXIA PHARMACEUTICALS Filed by: DISBROW ROBERT
Medium
Report
Form SC 13G EUPRAXIA PHARMACEUTICALS Filed by: DISBROW ROBERT
11/13
06:02 am
eprx
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 12
High
Report
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 12
11/8
11:50 am
eprx
Form D EUPRAXIA PHARMACEUTICALS
Low
Report
Form D EUPRAXIA PHARMACEUTICALS
11/7
05:20 pm
eprx
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 07
Low
Report
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 07
11/7
04:12 pm
eprx
Form SC 13D EUPRAXIA PHARMACEUTICALS Filed by: Freedman Joseph S.
Low
Report
Form SC 13D EUPRAXIA PHARMACEUTICALS Filed by: Freedman Joseph S.
11/1
06:03 am
eprx
Form 6-K EUPRAXIA PHARMACEUTICALS For: Oct 31
High
Report
Form 6-K EUPRAXIA PHARMACEUTICALS For: Oct 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: